XENE FY 2016 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-88.4% YoY

Gross Profit

$689,00038.2% margin

Operating Income

-$25M-1376.4% margin

Net Income

-$23M-1275.5% margin

EPS (Diluted)

$-1.48

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$67M

Total Liabilities

$4M

Stockholders' Equity

$64M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$16M	-88.4%
Gross Profit	$689,000	$13M	-94.6%
Operating Income	-$25M	-$9M	-165.1%
Net Income	-$23M	-$16M	-46.0%